4.5 Article

Rationale and protocol for a cluster randomized pragmatic clinical trial testing behavioral economic implementation strategies to improve tobacco treatment rates for cancer patients who smoke

Journal

IMPLEMENTATION SCIENCE
Volume 16, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13012-021-01139-7

Keywords

Tobacco use; Tobacco use treatment; Behavioral economics; Electronic health record; Pragmatic trials

Funding

  1. National Cancer Institute [P50 CA244690]

Ask authors/readers for more resources

This study aims to compare the effectiveness of nudges in promoting patient engagement with tobacco use treatment services among cancer patients. Data will be collected through electronic medical records, clinician surveys, and semi-structured interviews to assess the impact of nudges on referral rates and patient engagement. Results will provide insights into improving uptake of evidence-based tobacco use treatment and understanding contextual factors influencing response to implementation strategies.
Background: Routine evidence-based tobacco use treatment minimizes cancer-specific and all-cause mortality, reduces treatment-related toxicity, and improves quality of life among patients receiving cancer care. Few cancer centers employ mechanisms to systematically refer patients to evidence-based tobacco cessation services. Implementation strategies informed by behavioral economics can increase tobacco use treatment engagement within oncology care. Methods: A four-arm cluster-randomized pragmatic trial will be conducted across nine clinical sites within the Implementation Science Center in Cancer Control Implementation Lab to compare the effect of behavioral economic implementation strategies delivered through embedded messages (or nudges) promoting patient engagement with the Tobacco Use Treatment Service (TUTS). Nudges are electronic medical record (EMR)-based messages delivered to patients, clinicians, or both, designed to counteract known patient and clinician biases that reduce treatment engagement. We used rapid cycle approaches (RCA) informed by relevant stakeholder experiences to refine and optimize our implementation strategies and methods prior to trial initiation. Data will be obtained via the EMR, clinician survey, and semi-structured interviews with a subset of clinicians and patients. The primary measure of implementation is penetration, defined as the TUTS referral rate. Secondary outcome measures of implementation include patient treatment engagement (defined as the number of patients who receive FDA-approved medication or behavioral counseling), quit attempts, and abstinence rates. The semi-structured interviews, guided by the Consolidated Framework for Implementation Research, will assess contextual factors and patient and clinician experiences with the nudges. Discussion: This study will be the first in the oncology setting to compare the effectiveness of nudges to clinicians and patients, both head-to-head and in combination, as implementation strategies to improve TUTS referral and engagement. We expect the study to (1) yield insights into the effectiveness of nudges as an implementation strategy to improve uptake of evidence-based tobacco use treatment within cancer care, and (2) advance our understanding of the multilevel contextual factors that drive response to these strategies. These results will lay the foundation for how patients with cancer who smoke are best engaged in tobacco use treatment and may lead to future research focused on scaling this approach across diverse centers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda

Elisabeth F. Beaber, Aruna Kamineni, Andrea N. Burnett-Hartman, Brian Hixon, Sarah C. Kobrin, Christopher I. Li, Malia Oliver, Katharine A. Rendle, Celette Sugg Skinner, Kaitlin Todd, Yingye Zheng, Rebecca A. Ziebell, Erica S. Breslau, Jessica Chubak, Douglas A. Corley, Robert T. Greenlee, Jennifer S. Haas, Ethan A. Halm, Stacey Honda, Christine Neslund-Dudas, Debra P. Ritzwoller, Joanne E. Schottinger, Jasmin A. Tiro, Anil Vachani, V. Paul Doria-Rose

Summary: PROSPR II consortium aims to improve cancer screening processes and reduce disparities by investigating factors affecting cervical, colorectal, and lung cancer screening. They collected screening data from over 9 million racially and ethnically diverse individuals and identified variations in patient, provider, and facility characteristics across different communities.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Immunology

I Know That I Was a Part of Making a Difference: Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption

Rebecca Neergaard, Nora L. Jones, Christopher Roebuck, Katharine A. Rendle, Zoe Barbati, Beth Peterson, Pablo Tebas, Karam Mounzer, David Metzger, Luis J. Montaner, Karine Dube, Frances K. Barg

Summary: Analytical treatment interruption (ATI), a clinical pause in antiretroviral therapy (ART) monitored closely, is an important component of HIV cure-directed clinical studies. This study aimed to understand the motivations and decision-making processes of participants enrolling in the BEAT-2 cure-directed trial, as well as their perceptions of ATI. The majority of participants were driven by a desire to find a cure for HIV and help others in the HIV community. While altruism was a primary motivation, participants also expressed interest in learning about HIV science and research. They displayed a strong understanding of trial procedures and trust in the study team, but also expressed anxiety about the potential ineffectiveness of their previous ART regimen after resuming ART.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2023)

Letter Critical Care Medicine

Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence

Roger Y. Kim, Katharine A. Rendle, Nandita Mitra, Chelsea A. Saia, Christine Neslund-Dudas, Robert T. Greenlee, Andrea N. Burnett-Hartman, Stacey A. Honda, Michael J. Simoff, Marilyn M. Schapira, Jennifer M. Croswell, Rafael Meza, Debra P. Ritzwoller, Anil Vachani

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Review Oncology

Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem

Stephanie Markovina, Katharine A. Rendle, Alexander C. Cohen, Lindsay M. Kuroki, Surbhi Grover, Julie K. Schwarz

Summary: Cervical cancer is characterized by significant socioeconomic and racial disparities in various aspects including incidence, mortality, morbidity, and years of life lost. The standard-of-care treatment for locally advanced cervical cancer has not seen significant innovation since 1999, and current chemoradiation therapy has a failure rate of 30%-50% with no cure for recurrent or metastatic disease. The National Institutes of Health recognizes the urgent need to address the global clinical problem of cervical cancer morbidity and mortality, and efforts are being made to advance research in this area. This review discusses the state of the science and opportunities for improving cervical cancer survival, with a focus on improving access, utilizing technology in innovative ways, and enhancing the current understanding of cervical cancer biology.

CANCER (2022)

Article Medicine, General & Internal

Perspectives of Academic Oncologists About Offering Expanded Access to Investigational Drugs

Patrick Gould, Tasnim Salam, Laura Kimberly, Alison Bateman-House, Holly Fernandez Lynch

Summary: This qualitative study examines how oncologists at academic medical centers perceive expanded access (EA) to investigational medical products. The results show that oncologists view EA as an important tool to secure the best treatment options for their patients and are willing to pursue EA as part of their obligation. They also express confidence in evaluating investigational treatments and do not necessarily view EA as a last resort.

JAMA NETWORK OPEN (2022)

Article Public, Environmental & Occupational Health

Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening

Andrea N. Burnett-Hartman, Nikki M. Carroll, Jennifer M. Croswell, Robert T. Greenlee, Stacey A. Honda, Christine M. Neslund-Dudas, Roger Y. Kim, Katharine A. Rendle, Anil Vachani, Debra P. Ritzwoller

Summary: The authors aimed to determine the percentage of individuals up-to-date with lung cancer screening testing and evaluate differences based on patient and health system characteristics. The study found that only 28.3% of eligible individuals were up-to-date with testing. Factors associated with being up-to-date included age, chronic obstructive pulmonary disease, socioeconomic status, while factors inversely associated included smoking, BMI, ethnicity, and the type of lung cancer screening program.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2023)

Letter Critical Care Medicine

Treatment Is the Key to Addressing Tobacco Dependence

David P. L. Sachs, Palo Alto, Frank T. Leone, Brendan T. Heiden, Li-Shiun Chen, Varun Puri

CHEST (2023)

Article Public, Environmental & Occupational Health

The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who Smoke

Patricia A. Cioe, Robert Schnoll, Bettina B. Hoeppner, Robert Gross, Brian L. Hitsman, Frank T. Leone, Rebecca Ashare, Roger Vilardaga, Karen Tashima, Megan Pinkston, Christopher W. Kahler

Summary: People with HIV have higher smoking rates and the COVID-19 pandemic has impacted their smoking behaviors, with some reporting increased smoking. Worrying about food and greater COVID-related worry were significantly associated with increased smoking.

AIDS AND BEHAVIOR (2023)

Editorial Material Critical Care Medicine

Patient-Oriented Tools for Communicating Lung Cancer Screening Results The First of Many Critical Components

Katharine A. Rendle, Anil Vachani

CHEST (2023)

Review Oncology

Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review

Kevin Selby, Mai Sedki, Emma Levine, Aruna Kamineni, Beverly B. Green, Anil Vachani, Jennifer S. Haas, Debra P. Ritzwoller, Jennifer M. Croswell, Kabiru Ohikere, V. Paul Doria-Rose, Katharine A. Rendle, Jessica Chubak, Jennifer Elston Lafata, John Inadomi, Douglas A. Corley

Summary: This study reviewed guidelines for breast, cervical, colorectal, and lung cancer screening and summarized the relevant quality assessment metrics. The results showed that there are more metrics and supporting evidence in the guidelines for breast and colorectal cancer screening, while fewer metrics and no supporting evidence were found for cervical and lung cancer screening.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Letter Medicine, General & Internal

Navigating the Expanded Access Pathway to Investigational Drugs as an Academic Oncologist

Holly Fernandez Lynch, Tasnim Salam, Patrick Gould, Alison Bateman-House, Laura Kimberly

JAMA NETWORK OPEN (2023)

Article Medicine, Research & Experimental

Application of team science best practices to the project management of a large, multi-site lung cancer screening research consortium

Julie S. Steiner, Erica Blum-Barnett, Betsy Rolland, Courtney R. Kraus, Jocelyn V. Wainwright, Ruth Bedoy, Yannica Theda Martinez, Elizabeth R. Alleman, Roxy Eibergen, Lisa E. Pieper, Nikki M. Carroll, Brian Hixon, Andrew Sterrett, Katharine A. Rendle, Chelsea Saia, Anil Vachani, Debra P. Ritzwoller, Andrea Burnett-Hartman

Summary: This manuscript describes how the PROSPR-Lung consortium utilized evidence-based SciTS best practices to establish infrastructure and processes for translational research in lung cancer screening. Specific examples are provided for developing a shared mission, transparent leadership, research support systems, efficient data management, interdisciplinary conversations, and a culture of trust. Guidance is offered for managing a multi-site research center and data repository, along with project management tools and processes to drive collaboration, efficiency, and scientific productivity.

JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Pediatrics

Determinants of Blood Culture Use in Critically Ill Children: A Multicenter Qualitative Study

Charlotte Z. Woods-Hill, Maria N. Nelson, Whitney Eriksen, Katharine A. Rendle, Rinad S. Beidas, Christopher P. Bonafide, Michelle R. Brajcich, Aaron M. Milstone, Judy A. Shea

Summary: Blood cultures are crucial for diagnosing and treating sepsis in the pediatric intensive care unit, but there is significant variation in practices. Understanding the reasons behind blood culture use and overuse is important to optimize patient care. This study identified various factors influencing blood culture use, including clinician characteristics and behavioral economics concepts.

PEDIATRIC QUALITY & SAFETY (2023)

Article Psychology, Clinical

Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation

Robert Schnoll, Gabrielle M. Barrila, ShelDan Dalsimer, Mackenzie Hosie Quinn, Anna-Marika Bauer, Erica Fox, Matthew Olonoff, Nancy C. Jao, Frank Leone, Mark D. Huffman, Sadiya S. Khan, Jacqueline K. Gollan, George D. Papandonatos, Brian Hitsman

Summary: People with major depressive disorder (MDD) have high rates of tobacco use and lower responsiveness to tobacco cessation treatments. Treatment adherence plays a significant role in treatment outcomes, but its impact on smokers with MDD has not been evaluated. Factors such as demographic characteristics, smoking and psychiatric characteristics, withdrawal symptoms, and treatment-related side effects are associated with treatment adherence. Improving rates of treatment adherence can enhance cessation outcomes.

ADDICTIVE BEHAVIORS (2023)

Article Public, Environmental & Occupational Health

Advancing health equity through implementation science: Identifying and examining measures of the outer setting

Erica T. Warner, Nathalie Huguet, Michelle Fredericks, Daniel Gundersen, Andrea Nederveld, Meagan C. Brown, Thomas K. Houston, Kia L. Davis, Stephanie Mazzucca, Katharine A. Rendle, Karen M. Emmons

Summary: This study developed a data resource to assess the outer setting across seven center funded by the National Cancer Institute's IS Centers in Cancer Control (ISC3) Network program. The results showed that the outer setting varies across these centers and often differs from the national level.

SOCIAL SCIENCE & MEDICINE (2023)

No Data Available